Skip to content

Determination of the Glycemic Index Values of 10 Cereal-based Products

Determination of the Glycemic Index Values of 10 Cereal-based Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06710743
Enrollment
10
Registered
2024-11-29
Start date
2024-07-01
Completion date
2024-09-27
Last updated
2024-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Low Glycemic Index (GI) Food, Pre Diabetes

Keywords

Low GI food, glycemic index, cereal, carbohydrate, glucose

Brief summary

To determine the Glycemic index values for 10 cereal-based products

Detailed description

To determine the Glycemic index values for 10 cereal-based products per international standard (ISO26642:2010) for glycemic index determination.

Interventions

OTHERGlucose solution Day 1, Day 8, and Day 15

Glucodin powder diluted with water

OTHERFood (cereal). Ten different cereals served once each

Variety of cooked or flake cereal

Sponsors

PepsiCo Global R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* 10 healthy participants, male and female (non-pregnant, non-lactating) of mixed ethnicity, aged between 18 - 65 y * BMI: 18 - 25.0 kg/m2 (bounds included) * Non smokers * Normal glucose tolerance (assessed by 50 gram oral glucose tolerance test performed within the last 30 days: fasting \<6 mM, 2 hr glucose \<7.8 mM) * Stable weight and dietary habits. Normal eating patterns and no history of eating disorders or recent dieting * Normal sleep patterns (ie. at least 6 hours of sleep per night) * The participants are required to avoid alcohol and unusual levels of food intake and physical activity for the 24 hours before each test session. * Absence of health conditions that would prevent fulfillment of study requirements as judged by the Investigator on the basis of medical history. Understanding the study procedures and willing to provide informed consent to participate in the study and authorization to release relevant protected health information to the study investigator.

Exclusion criteria

* Food allergy or intolerance to the study ingredients (eg. gluten, etc.) * Regularly taking prescription medication other than standard contraceptive medication * Taking any medications known to affect glucose tolerance (eg. acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis) * Suffering from any illness or disease * Following a restricted diet * Smokers * Eating disorders * Abnormal glucose tolerance or known history of diabetes mellitus. * Individuals currently participating in other acute metabolic studies * Failure to meet any one of the inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Glycemic index (GI) valuesTwo hour test session per visit. Visits must be at least two days apart. Including Screening, the study duration is approximately four to eleven weeks depending on whether participants are available to be tested one, two or three times per week.Comparison of Glycemic index (GI) values of 10 different cereal-based products and the reference food (glucose solution assigned GI=100 by definition)

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026